Skip to main content
Pediatrics logoLink to Pediatrics
. 2016 Nov;138(5):e20154664. doi: 10.1542/peds.2015-4664

Complementary and Alternative Medicine and Influenza Vaccine Uptake in US Children

William K Bleser 1, Bilikisu Reni Elewonibi 1, Patricia Y Miranda 1, Rhonda BeLue 1,
PMCID: PMC5079075  PMID: 27940756

Abstract

BACKGROUND:

Complementary and alternative medicine (CAM) is increasingly used in the United States. Although CAM is mostly used in conjunction with conventional medicine, some CAM practitioners recommend against vaccination, and children who saw naturopathic physicians or chiropractors were less likely to receive vaccines and more likely to get vaccine-preventable diseases. Nothing is known about how child CAM usage affects influenza vaccination.

METHODS:

This nationally representative study analyzed ∼9000 children from the Child Complementary and Alternative Medicine File of the 2012 National Health Interview Survey. Adjusting for health services use factors, it examined influenza vaccination odds by ever using major CAM domains: (1) alternative medical systems (AMS; eg, acupuncture); (2) biologically-based therapies, excluding multivitamins/multiminerals (eg, herbal supplements); (3) multivitamins/multiminerals; (4) manipulative and body-based therapies (MBBT; eg, chiropractic manipulation); and (5) mind–body therapies (eg, yoga).

RESULTS:

Influenza vaccination uptake was lower among children ever (versus never) using AMS (33% vs 43%; P = .008) or MBBT (35% vs 43%; P = .002) but higher by using multivitamins/multiminerals (45% vs 39%; P < .001). In multivariate analyses, multivitamin/multimineral use lost significance, but children ever (versus never) using any AMS or MBBT had lower uptake (respective odds ratios: 0.61 [95% confidence interval: 0.44–0.85]; and 0.74 [0.58–0.94]).

CONCLUSIONS:

Children who have ever used certain CAM domains that may require contact with vaccine-hesitant CAM practitioners are vulnerable to lower annual uptake of influenza vaccination. Opportunity exists for US public health, policy, and medical professionals to improve child health by better engaging parents of children using particular domains of CAM and CAM practitioners advising them.


What’s Known on This Subject:

Complementary and alternative medicine (CAM) is increasingly popular and is implicated in supporting antivaccine viewpoints. Some CAM practitioners advise alternative vaccination schedules or against vaccination. No previous studies about the association of child CAM usage and influenza vaccination were identified.

What This Study Adds:

US children who have ever used domains of CAM often requiring contact with CAM practitioners (eg, chiropractors, naturopathic physicians) have lower odds of influenza vaccination. Opportunity exists to improve child health by engaging their parents and their CAM practitioners.

Adverse effects of routinely recommended vaccines are markedly outweighed by their benefits, but the public is not trained to carefully weigh such risks and benefits.1 Coupled with the success of vaccines at preventing disease, this scenario has created a public health challenge: the current low incidence of most vaccine-preventable diseases often misleads the public to the misperception that the risks of these diseases are low and the costs/risks of the vaccines are comparatively high, resulting in relatively low vaccination program participation.2 Recently, there has been a rise in “antivaccine” and “vaccine-hesitant” sentiment in the United States.3 Vaccine hesitancy, which recognizes a spectrum of beliefs ranging from total vaccine acceptance to total vaccine refusal, is a complex and contextual issue and requires approaches at multiple levels, including addressing individuals, providers, health systems, and the nation.3,4 Vaccine hesitancy is heavily grounded in myths about vaccine-preventable diseases and their corresponding vaccines that are not supported by scientific evidence.57 However, vaccine hesitancy is also entwined with broader factors such as institutional trust, socioeconomic context, the media, social norms, and health beliefs, among others.3,4 Although vaccine hesitancy has received increasing empirical attention lately,4 it is an extremely important issue that requires more investigation.3

Complementary and alternative medicine (CAM), approaches to health that are not considered part of conventional medicine (eg, homeopathy, chiropractic manipulation, chelation therapy),8 have also recently risen in popularity as a form of health care. Estimates from the previous decade (pooled data from 2002, 2007, and 2012) show that one-third of the US population had used at least 1 type of CAM in the previous 12 months.9 The prevalence of CAM is highest among middle-aged, non-Hispanic white women of high socioeconomic status, as well as those with multiple health conditions and who frequently visit medical facilities.8,9 CAM is mostly used in conjunction with conventional medicine10 for prevention of diseases and to improve health and well-being11 and thus should not, in theory, interfere with vaccination uptake. However, CAM has been implicated as lending support to antivaccine/vaccine-hesitant viewpoints via criticism of vaccination, public health, and conventional medicine from adults using CAM,1214 as well as from CAM practitioners and practitioners-in-training.12,15,16 Even among CAM practitioners who generally support the concept of vaccination, a majority report they recommend a vaccine schedule different from the standard schedule put forth by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices.17

Influenza is a vaccine-preventable disease of particular importance in the United States, causing up to 200 000 hospitalizations,18 49 000 deaths,19 and an estimated $87 billion of economic burden annually.20 The association of CAM use and influenza vaccination in adults has been examined, although nationally representative findings are limited and conflicting: adults who use CAM may have significantly lower uptake,21 no difference in uptake,22 or higher uptake23 compared with non-CAM users. To the best of our knowledge, there has been no examination of the association of CAM use and influenza vaccination in US children.

This limitation of the literature is important for 2 primary reasons. First, US children are an extremely important population pertaining to influenza. They experience the highest rates of infection and serve as a major source of transmission in the family and community.2428 Children aged <5 years are a high-risk group because they are at increased danger of influenza-related complications and comprise a substantial portion of influenza-related morbidity and care visits.18,24,29,30 Influenza vaccination is recommended for all persons aged ≥6 months annually.25 In children, the vaccine is safe,31 widely available, and increasingly affordable,32,33 and although the effectiveness varies each year,34 influenza vaccines are immunologically efficacious and effective at preventing numerous outcomes.35 However, influenza vaccination uptake among US children is suboptimal36 and substantially lower than uptake of other recommended childhood vaccines.37 Second, CAM use in children is not uncommon, and the sparse literature available suggests that children using CAM are less likely to be vaccinated. National estimates from 2007 to 2012 show that nearly 12% of US children had used 1 type of CAM in the last 12 months.8,38 Child CAM use was more common among adolescents, non-Hispanic white children, and children whose parents had high levels of education, were not poor, and had private health insurance. Furthermore, a study of vaccine uptake (not including influenza) in Washington from 2000 to 2003 found that children who saw a naturopathic physician or chiropractor were less likely to receive recommended vaccines and more likely to be diagnosed with vaccine-preventable diseases,39 suggesting children who use CAM may be less likely to be vaccinated against influenza. The present study examines the association of CAM use with influenza vaccination in a nationally representative sample of US children.

Methods

Data Source and Study Population

This study uses data from 2012 National Health Interview Survey (NHIS), the most recent NHIS to include the Child Complementary and Alternative Medicine File (CAL). The NHIS annually collects information on the health of the US noninstitutionalized civilian population through household interviews of household adults.40 Houses were sampled by using multistage area probability design, and the total household response rate was 77.6%.41 The 2012 CAL collected information about all NHIS sample children aged 4 to 17 years (N = 10 218) on use of nonconventional health care practices (children aged <4 years are excluded from the CAL). Approximately 1.9% (n = 195) of the CAL respondents did not provide any responses to the CAL questions but are retained in the file as the missing values.41 All questions are reported by household adult respondents.

Dependent Variable

The dependent variable is parent-reported child receipt of an influenza vaccination within the previous 12 months from the NHIS Child Sample file.

Independent Variables

The CAL asks household adults if the child has used 37 types of CAM for health reasons both ever and within the previous 12 months. The prevalence of ever using CAM varied from 0.01% to 6.4% across all types of CAM except the use of multivitamins/multiminerals (62.3%). We used the “ever” questions because although the prevalences are still small, they are larger than the “previous 12 months” questions. Using CAM literature as a guide, we grouped these 37 therapies across 4 domains developed by the National Center for Complementary and Alternative Medicine in 20124245: (1) alternative medical systems (AMS; eg, acupuncture); (2) biologically based therapies (BBTs; eg, herbal supplements); (3) manipulative and body-based therapies (MBBT; eg, chiropractic manipulation); and (4) mind–body therapies (MBT; eg, yoga) (Table 1). Variables were constructed representing having ever used at least 1 type of CAM separately for each domain (eg, ever using any type of AMS), as done in previous literature.44 Because the prevalence of ever using multivitamins/multiminerals was much higher than any other single CAM type, we hypothesized it to be different and separated it from other BBT types. Thus, the 5 independent variables in this study are ever using, for health reasons, the following: (1) any AMS type; (2) any BBT type, excluding multivitamins/multiminerals; (3) multivitamins/multiminerals; (4) any MBBT type; and (5) any MBT type.

TABLE 1.

Prevalence of Ever Using CAM, US Children Aged 4 to 17 Years, 2012 NHIS

CAM Categories and Subtypes Prevalence (%) N
AMS for health reasons
 Acupuncture 0.22 25
 Naturopathy 0.70 62
 Homeopathy 3.09 281
 Ayurveda 0.11 9
 Traditional healer (includes Curandero or Parchero; Native-American health or medicine man; medicine shaman; Sobrador; Yerbero or Hierbista; or Huesero) 0.32 51
 Any AMS subtypea 3.80 359
BBT for health reasons
 Chelation therapy 0.10 7
 Herbal or other nonvitamin supplement 6.38 615
 Biofeedback 0.17 17
 Vegetarian (including vegan) diet for ≥2 wk 1.43 126
 Macrobiotic diet for ≥2 wk 0.08 11
 Atkins diet for ≥2 wk 0.03 4
 Pritikin diet for ≥2 wk 0.01 2
 Ornish diet for ≥2 wk 0.05 3
 Multivitamins or multimineralsa 62.33 6122
 Any BBT subtype (excluding multivitamins or multiminerals)a 7.55 718
 Any BBT subtype 63.49 6221
MBBT for health reasons
 Chiropractic or osteopathic manipulation 5.49 503
 Craniosacral therapy 0.32 28
 Massage 1.47 162
 Feldenkrais Method 0.10 6
 Pilates 0.11 105
 Trager psychophysical integration 0.04 3
 Alexander technique 0.06 5
 Any MBBT subtypea 7.32 686
MBT for health reasons
 Yoga 4.22 421
 Qigong 0.11 13
 Tai Chi 0.42 46
 Energy healing therapy 0.26 30
 Hypnosis 0.12 10
 Meditation, guided imagery, or progressive relaxation (includes progressive relaxation, guided imagery, mantra meditation, spiritual meditation, and mindfulness meditation) 1.38 137
 Any MBT subtypea 5.29 532
Summary measures
 Ever used any type of CAM (excluding multivitamins or multiminerals) 17.06 1648
 Ever used any type of CAM 65.89 6445

Percentages weighted to be nationally representative. N unweighted to show actual number of observations in each cell (may not add up to total N total due to missing values).

a

Used as independent variables in this study.

Covariates

The selection of covariates was conceptually grounded in Andersen’s Behavioral Model of Health Services Use.46 This model has been used in varying health settings to study different health outcomes,47 and it provides conceptual factors influencing health service use (influenza vaccination) at more distal levels (predisposing, enabling, and creating need), as well as the more intermediary health behavior level. Using this model, 13 covariates were selected. At the child level, these covariates were: sex (female/male); age (years); race/ethnicity (non-Hispanic white; non-Hispanic black or African American; non-Hispanic Asian; non-Hispanic other or multiple race; and Hispanic); usual source of care they go to when the child is sick or the parent needs advice about the child’s health (yes/no); well-child checkup in the previous 12 months (yes/no); number of physician visits in the previous 12 months; US-born status (yes/no); presence of at least 1 serious chronic condition or limitation (yes/no [defined as having 1 of the following: Down syndrome, cerebral palsy, muscular dystrophy, cystic fibrosis, sickle cell anemia, autism or autism spectrum disorder, type 1 diabetes mellitus, arthritis, congenital heart disease, or other heart condition]); asthma status (yes/no); and insurance type (private, public, or no coverage). At the family level, these covariates were: highest family education (less than high school, completed high school or the General Educational Development test, associate’s degree or some college [no degree], or bachelor’s degree or higher); family income as a percentage of the federal poverty level (<100%, 100%–199%, or ≥200%); and language of interview (English only or other). These variables come from the NHIS Sample Child, Family, and Person files.

Analysis

Bivariate associations were used to show unadjusted associations between ever use of CAM domains and influenza vaccination uptake. Multivariate logistic regression was then used to examine these associations, adjusting for factors of health services use (n = 8981–8989 across CAM domains), as well as in 1 model including all CAM domain variables to adjust for ever using other types of CAM (n = 8947). Analyses were conducted by using Stata/MP 14.1 with preconstructed NHIS weights41 and Stata’s svy commands to obtain nationally representative results and SEs accounting for complex survey design.48 We obtained exempt status from the institutional review board of Pennsylvania State University.

Results

The percentage of sample children who had ever used multivitamins or multiminerals was 62%; otherwise, the percentages ever using any subtype of AMS, BBT, MBBT, and MBT CAM domains were 3.8%, 7.6%, 7.3%, and 5.3%, respectively. Overall, 43% of sample children received an influenza vaccine in the previous 12 months. Sample children were predominantly native-born, non-Hispanic white, and privately insured, did not have asthma or serious chronic condition/limitations, and had a usual source of care, annual well-child evaluations, and physician visits. They lived with English-speaking families with at least some college education and income above the poverty line (Table 2).

TABLE 2.

Descriptive Statistics of Study Population, US Children Aged 4 to 17 Years, 2012 NHIS

Variable % or Mean ± SD N
Outcome variable
 Received influenza vaccination, previous 12 mo 42.72 4246
 Did not receive influenza vaccination, previous 12 mo 57.28 5633
Independent variables
 Ever used any AMS CAM subtype for health reasons 3.80 359
 Ever used any BBT CAM subtype for health reasons (excluding multivitamins or multiminerals) 7.55 718
 Ever taken multivitamins or multiminerals for health reasons 62.33 6122
 Ever used any MBBT CAM subtype for health reasons 7.32 686
 Ever used any MBT CAM subtype for health reasons 5.29 532
Covariates
 Sex
  Female 48.87 5012
  Male 51.13 5206
 Age, y 10.52 ± 4.03 10 218
 Race/ethnicity
  Non-Hispanic white 53.69 4559
  Non-Hispanic black or African American 13.40 1570
  Non-Hispanic Asian 4.39 586
  Non-Hispanic other or multiple race 5.05 557
  Any Hispanic 23.47 2946
 Child has a usual source of care they go to when sick
  Yes 95.80 9696
  No 4.20 508
 Had a well-child checkup, previous 12 mo
  Yes 77.37 7747
  No 22.63 2377
 Child born in the United States
  Yes 95.30 9620
  No 4.70 595
 Total no. of physician office visits, previous 12 mo
  None 9.96 1118
  1 25.43 2548
  2–3 38.13 3869
  4–5 13.44 1307
  ≥6 13.05 1264
 Child has ≥1 serious chronic condition/limitationa
  No 96.56 9860
  Yes 3.44 351
 Ever been told child has asthma
  No 83.75 8466
  Yes 16.25 1743
 Insurance type
  Any private 53.95 5131
  Only public 39.03 4208
  No coverage 7.03 829
 Highest family education
  Less than high school 10.56 1161
  Completed high school or GED 18.88 2107
  Associate’s degree or some college (no degree) 34.44 3587
  Bachelor’s degree or higher 36.13 3354
 Family income as a percentage of the federal poverty level
  <100% 20.73 2060
  100% to 199% 22.90 2238
   ≥200% 56.38 5207
 Language of interview
  English only 90.34 8873
  Other 9.66 1260

Percentages weighted to be nationally representative. N unweighted to show actual observations (may not add up to total N total due to missing values). GED, General Educational Development test.

a

Down syndrome, cerebral palsy, muscular dystrophy, cystic fibrosis, sickle cell anemia, autism or autism spectrum disorder, type 1 diabetes mellitus, arthritis, congenital heart disease, or other heart condition.

In unadjusted analyses, uptake was lower among children who had ever (versus never) used AMS (33% vs 43%; P = .008) and MBBT (35% vs 43%; P = .002). Conversely, uptake was higher among children who ever (versus never) used multivitamins/multiminerals (45% vs 39%; P < .001). There was no significant association in children by ever using any BBT or MBT. Across covariates, significantly lower uptake was seen in children according to race/ethnicity (lowest: non-Hispanic white children) and with each increasing year of age. Lower uptake was also noted in children: without a usual source of care; without a recent well-child checkup; without serious chronic conditions/limitations; without asthma; with no insurance coverage; with decreasing recent physician visits; and in families with some college but no degree (Table 3).

TABLE 3.

Bivariate Correlates of Influenza Vaccination, US Children Aged 4 to 17 Years, 2012 NHIS

Categorical Variables Unvaccinated Vaccinated P
N % or Mean ± SE N % or Mean ± SE
Ever used any AMS CAM subtype for health reasons .008
 No 5359 57.03 4095 42.97
 Yes 243 66.73 115 33.27
Ever used any BBT CAM subtype for health reasons (excluding multivitamins or multiminerals) .150
 No 5157 57.18 3930 42.82
 Yes 441 60.68 271 39.32
Ever taken multivitamins or multiminerals for health reasons <.001
 No 2274 60.64 1499 39.36
 Yes 3328 55.49 2702 44.51
Ever used any MBBT CAM subtype for health reasons .002
 No 5165 56.76 3958 43.24
 Yes 435 65.47 246 34.53
Ever used any MBT CAM subtype for health reasons .957
 No 5296 57.44 3982 42.56
 Yes 306 57.29 221 42.71
Sex .803
 Female 2748 57.46 2096 42.54
 Male 2885 57.12 2150 42.88
Age, y 5633 10.99 ± 0.071 4246 9.84 ± 0.080 <.001
Race/ethnicity <.001
 Non-Hispanic white 2660 60.16 1748 39.84
 Non-Hispanic black or African American 868 57.86 635 42.14
 Non-Hispanic Asian 278 46.68 292 53.32
 Non-Hispanic Other or multiple race 260 49.26 273 50.74
 Any Hispanic 1567 54.08 1298 45.92
Child has a usual source of care they go to when sick <.001
 Yes 5255 56.38 4128 43.62
 No 374 78.03 116 21.97
Had a well-child checkup, previous 12 mo <.001
 Yes 3899 51.85 3621 48.15
 No 1708 75.53 614 24.47
Child born in the United States .485
 Yes 5320 57.37 3980 42.63
 No 312 55.53 265 44.47
No. of physician visits, previous 12 mo <.001
 None 841 77.56 255 22.44
 1 1582 64.35 907 35.65
 2–3 1976 53.48 1774 46.52
 4–5 637 48.69 641 51.31
 ≥6 578 47.92 650 52.08
Child has ≥1 serious chronic condition/limitationa .038
 No 5466 57.53 4070 42.47
 Yes 163 50.44 173 49.56
Ever been told child has asthma <.001
 No 4787 58.78 3402 41.22
 Yes 843 49.61 840 50.39
Insurance type <.001
 Any private 2867 58.46 2091 41.54
 Only public 2157 52.54 1918 47.46
 No coverage 580 74.23 223 25.77
Highest family education <.001
 Less than high school 571 51.36 544 48.64
 High school or GED 1166 57.68 859 42.32
 Associate’s degree, or some college (no degree) 2086 61.06 1387 38.94
 Bachelor’s degree or higher 1804 55.18 1453 44.82
Family incomes, % of federal poverty level .672
 <100% 1113 56.22 882 43.78
 100%–199% 1237 58.04 927 41.96
  ≥200% 2902 57.37 2153 42.63
Language of interview .165
 English only 4919 57.47 3651 42.53
 Other 671 55.05 560 44.95

Percentages and means weighted to be nationally representative; SEs adjusted for complex survey design. GED, General Educational Development test.

a

Down syndrome, cerebral palsy, muscular dystrophy, cystic fibrosis, sickle cell anemia, autism or autism spectrum disorder, type 1 diabetes mellitus, arthritis, congenital heart disease, or other heart condition.

Results from multivariate analyses adjusting for all health services use covariates had similar significant results (Table 4). Children ever using any type of AMS, or any type of MBBT, had lower odds of influenza vaccination in the previous 12 months compared with those never using those types of CAM (adjusted odds ratios of 0.61 [95% confidence interval: 0.44–0.85] and 0.74 [95% confidence interval: 0.58–0.94], respectively). There were still no significant differences in odds of uptake among children ever using BBT or MBT, and having ever used multivitamins or multiminerals was no longer significant. Adding all CAM domains variables together in one model, the MBBT outcome moved just outside of significance (odds ratio: 0.78 [95% confidence interval: 0.61–1.00]).

TABLE 4.

ORs of Influenza Vaccination From Logistic Regression Models, US Children Aged 4 to 17 Years, 2012

Variable Any AMS Any BBT (Except Multivitamins/Multiminerals) (n = 9799) Multivitamins or Multiminerals (n = 9803) Any MBBT (n = 9804) Any MBT (n = 9805) Any CAM (n = 9759)
(n = 9812) (n = 9799) (n = 9803) (n = 9804) (n = 9805) (n = 9759)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Unadjusted logistic regression
 Ever used any AMS type for health reasons (ref: no) 0.66 (0.49–0.90)** 0.70 (0.50– 0.96)*
 Ever used any BBT type (except multivitamins/multiminerals) for health reasons (ref: no) 0.87 (0.71– 1.05) 0.93 (0.75 to 1.17)
 Ever used multivitamins/multiminerals for health reasons (ref: no) 1.24 (1.10–1.39)*** 1.26 (1.13–1.42)***
 Ever used any MBBT type for health reasons (ref: no) 0.69 0.55–0.87)** 0.71 (0.56–0.90)**
 Ever used any MBT type for health reasons (ref: no) 1.01 (0.80–1.27) 1.12 (0.88–1.43)
(n = 8989) (n = 8982) (n = 8984) (n = 8981) (n = 8983) (n = 8947)
aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Multivariate logistic regression
 Ever used any AMS type for health reasons (ref: no) 0.61 (0.44–0.85)** 0.64 (0.45–0.91)*
 Ever used any BBT type (except multivitamins/multiminerals) for health reasons (ref: no) 0.83 (0.68–1.02) 0.91 (0.73–1.14)
 Ever used multivitamins/multiminerals for health reasons (ref: no) 1.12 (0.98–1.28) 1.13 (0.99–1.29)
 Ever used any MBBT type for health reasons (ref: no) 0.74 (0.58–0.94)* 0.78 (0.61–1.00)
 Ever used any MBT type for health reasons (ref: no) 1.01 (0.78–1.32) 1.14 (0.86–1.50)
 Female (versus male) 1.00 (0.89–1.13) 1.00 (0.88–1.13) 1.01 (0.89–1.14) 1.00 (0.89–1.14) 1.00 (0.88–1.13) 1.01 (0.89–1.14)
 Age (years, decreasing) 1.06 (1.05–1.08)*** 1.06 (1.05–1.08)*** 1.06 (1.05–1.08)*** 1.06 (1.04–1.07)*** 1.06 (1.05–1.08)*** 1.06 (1.04–1.07)***
 Race/ethnicity (ref: non-Hispanic white)
 Non-Hispanic black or African American 1.02 (0.87–1.21) 1.04 (0.88–1.23) 1.05 (0.88–1.23) 1.02 (0.86–1.20) 1.04 (0.88–1.22) 1.01 (0.86–1.20)
 Non-Hispanic Asian 1.90 (1.45–2.47)*** 1.92 (1.47–2.50)*** 1.91 (1.46–2.49)*** 1.87 (1.44–2.44)*** 1.91 (1.47–2.49)*** 1.87 (1.44–2.44)***
 Non-Hispanic other or multiple race 1.42 (1.05–1.90)* 1.43 (1.06–1.92)* 1.40 (1.04–1.88)* 1.42 (1.05–1.92)* 1.41 (1.05–1.90)* 1.42 (1.06–1.91)*
 Any Hispanic 1.34 (1.13–1.58)** 1.35 (1.14–1.59)*** 1.35 (1.14–1.59)*** 1.34 (1.13–1.58)** 1.35 (1.15–1.60)*** 1.34 (1.13–1.58)**
 Has a usual source of care to go to (versus does not) 1.38 (0.99–1.93) 1.39 (0.99–1.93) 1.41 (1.01–1.97)* 1.40 (1.00–1.95)* 1.40 (1.00–1.95) 1.39 (0.99–1.95)
 Well-child visit, previous 12 mo (versus had none) 2.22 (1.92–2.55)*** 2.22 (1.92–2.55)*** 2.22 (1.93–2.56)*** 2.20 (1.91–2.53)*** 2.22 (1.92–2.55)*** 2.20 (1.91–2.53)***
 No. of physician visits, previous 12 mo (ref: none)
  1 1.16 (0.92–1.47) 1.17 (0.92–1.48) 1.15 (0.90–1.45) 1.15 (0.91–1.46) 1.16 (0.91–1.47) 1.16 (0.91–1.47)
  2–3 1.74 (1.38–2.19)*** 1.76 (1.40–2.21)*** 1.70 (1.35–2.14)*** 1.75 (1.38–2.20)*** 1.73 (1.38–2.18)*** 1.73 (1.37–2.19)***
  4–5 1.99 (1.55–2.56)*** 2.00 (1.56–2.57)*** 1.93 (1.51–2.47)*** 1.98 (1.54–2.54)*** 1.97 (1.53–2.52)*** 1.98 (1.54–2.55)***
  ≥6 2.17 (1.67–2.83)*** 2.18 (1.68–2.83)*** 2.08 (1.60–2.70)*** 2.17 (1.66–2.82)*** 2.13 (1.64–2.78)*** 2.19 (1.68–2.86)***
 Child has ≥1 serious chronic condition/limitationa (versus not) 1.17 (0.88–1.55) 1.17 (0.88–1.55) 1.15 (0.87–1.53) 1.20 (0.91–1.60) 1.17 (0.87–1.55) 1.22 (0.92–1.62)
 Child has ever been told they have asthma (versus not) 1.33 (1.14–1.55)*** 1.32 (1.14–1.54)*** 1.33 (1.14–1.55)*** 1.33 (1.14–1.55)*** 1.32 (1.13–1.54)*** 1.32 (1.13–1.54)***
 Child is foreign-born (versus born in the United States) 1.29 (1.01–1.66)* 1.29 (1.00–1.65)* 1.27 (<1.00–1.63) 1.29 (1.01–1.65)* 1.27 (1.00–1.65)* 1.29 (1.00–1.65)*
 Insurance type (ref: any private)
  Public only 1.19 (0.99, 1.42) 1.19 (<1.00–1.42) 1.19 (<1.00–1.43) 1.19 (<1.00–1.43) 1.19 (<1.00–1.43) 1.19 (0.99–1.42)
  No coverage 0.69 (0.52–0.91)* 0.69 (0.52–0.92)* 0.69 (0.52–0.92)* 0.69 (0.52–0.91)** 0.69 (0.52–0.91)* 0.68 (0.51–0.90)**
 Highest family education (ref: bachelor’s degree or higher)
  Less than high school 1.24 (0.98–1.57) 1.24 (0.98–1.58) 1.27 (1.00–1.62)* 1.26 (0.99–1.60) 1.26 (0.99–1.60) 1.27 (<1.00–1.63)
  High school or GED 0.97 (0.82–1.15) 0.98 (0.83–1.16) 1.00 (0.85–1.18) 0.97 (0.83–1.15) 0.99 (0.84–1.17) 0.98 (0.82–1.15)
  Associate’s degree or some college (no degree) 0.83 (0.72–0.96)* 0.83 (0.72–0.96)* 0.83 (0.72–0.96)* 0.83 (0.71–0.96)* 0.84 (0.72–0.97)* 0.83 (0.71–0.96)*
 Family income, % of federal poverty level (ref: <100%)
  100%–199% 1.10 (0.91–1.33) 1.09 (0.91–1.32) 1.08 (0.90–1.31) 1.09 (0.91–1.32) 1.09 (0.91–1.32) 1.08 (0.90–1.31)
  ≥200% 1.23 (<1.00–1.51) 1.24 (1.00–1.52)* 1.22 (0.99–1.50) 1.23 (1.00–1.52)* 1.23(<1.00–1.52) 1.21 (0.99–1.50)
Interview only in English language (versus other language) 1.03 (0.84–1.27) 1.03 (0.83–1.27) 1.02 (0.83–1.26) 1.05 (0.85–1.29) 1.03 (0.84–1.28) 1.03 (0.83–1.27)

Odds ratios (ORs) weighted to be nationally representative; SEs adjusted for complex survey design. aOR, adjusted odds ratios.

a

Down syndrome, cerebral palsy, muscular dystrophy, cystic fibrosis, sickle cell anemia, autism or autism spectrum disorder, type 1 diabetes mellitus, arthritis, congenital heart disease, or other heart condition.

*

P < .05.

**

P < .01.

***

P < .001.

Looking at covariates across the columns in Table 4, there were several patterns of significant results. Compared with non-Hispanic white children, higher odds of influenza vaccination were seen in non-Hispanic Asian, non-Hispanic other or multiple race, and Hispanic children; there was no significant difference between black and white children. Compared with children with private insurance, children with no coverage during the year had lower odds of vaccination; there was no significant public–private difference. Higher odds of vaccination were recorded in children with a well-child visit in the previous year, with increasing number of physician visits, with each decreasing year of age, with asthma, and not born in the United States. There was a U-shaped pattern of vaccination odds according to family education, whereby the lowest and highest categories of education had the highest uptake.

Discussion

Although CAM is mostly used in conjunction with conventional medicine, the present study provides evidence that US children who have ever used any subtype of AMS or MBBT had lower odds of influenza vaccination. In our sample, the second most prevalent type of AMS was naturopathy, and the most prevalent type of MBBT was chiropractic or osteopathic manipulation. These specific types of CAM may require contact with CAM practitioners shown to have vaccine-critical viewpoints, advise against vaccination, or advise vaccine schedules different from those recommended by the federal government.12,1517,39 Because chiropractic manipulation is grouped in the survey question with osteopathic manipulation, it is possible that the association of MBBT use with lower vaccination odds is diluted if osteopathic physicians hold viewpoints closer to medical physicians and further from chiropractors. The MBBT finding moved just outside of significance when all CAM variables were included in 1 model; other CAM use may confound the relationship between MBBT use and influenza vaccination. In terms of the lack of a significant difference in uptake observed among children ever using BBT or MBT, we do not know if CAM practitioners are involved in the study children’s CAM use; it is plausible, however, that these types of CAM may involve less contact with CAM practitioners (eg, herbal supplements, alternative diets, and yoga are easily available for home use). More research is needed investigating these patterns.

Several covariates were also significantly associated with influenza vaccination uptake and warrant further investigation in a future, longitudinal study as potential mediators and/or moderators of influenza vaccine disparities in children. Consistent with other studies, we found higher uptake among the following groups of children: those with a higher number of recent provider visits4953 (which is conceptually related to having a well-child visit and a usual source of care, all of which are important given that physician recommendation of the vaccine is one of most commonly cited correlates of higher influenza vaccine uptake51,5465); those without health insurance66; those with asthma or parental worry about asthma51,67; and those of a younger age.5052,58,6870 Although we found no disparities between black and white children, we did observe higher uptake in Asian, Hispanic, and other/multiracial children. There were no significant racial/ethnic disparities nationally among children in most recent influenza seasons,69 although higher uptake among Asian children has been observed.70 Generally, higher parental education is associated with higher influenza vaccine uptake in children.56,68,70 However, this scenario is not always the case, and in this study we found the inverse association. Studies (not including influenza vaccination) have documented that parents who delay or refuse vaccinating their children in general tend to be college educated, higher income, white populations, and also tend to have lifestyles that include CAM use and alternative diets.14,7173 Perhaps not coincidentally, CAM is associated with higher income and higher education,74 which may partially explain the inverse education relationship we observed. Lastly, we found that foreign-born children had higher odds of vaccination compared with US-born children. Although we are unaware of studies examining the relationship of nativity/citizenship and influenza vaccination in US children, a recent study of Mexican adults in California found that higher influenza vaccine uptake diminishes after the first generation postmigration.75 Furthermore, a study of other vaccines found that having a foreign-born or noncitizen mother was associated with reduced odds or vaccination.76 More research is needed in these areas.

The findings of this study should be interpreted within its limitations. First, aggregating CAM therapies into domains masks the effects of individual therapies. Because the prevalence of ever using most individual CAM therapies in children in the NHIS was very small, we were not afforded the statistical opportunity to conduct such individual analyses. Furthermore, the use of the “ever” CAM questions instead of the “within the previous 12 months” questions, although necessary for power reasons, prevented us from discerning if these are children whose parents were having them “try out” CAM versus consistent CAM users. Second, the CAL excludes children aged <4 years, although children aged <5 years are at high risk for influenza complications.18,24,29,30 These are survey limitations; future studies should capture larger samples of children’s CAM use and include those aged 0 to 3 years. Related, both the CAM variables and the influenza vaccine question are parent-reported, creating potential recall bias, although for the latter, the influenza vaccine is recommended annually, lessening the time period that the parent needs to recall and thus also the chance of recall bias. Last, this study was cross-sectional, and therefore the findings are associative and not causal. We believe the possibility of bidirectionality in our findings, however, to be less likely. The reasons many use CAM include cultural and philosophical beliefs about health and health services, and CAM often aims to treat illness beyond the physical and biomedical contexts.43 Andersen’s model posits that such health beliefs, values, and knowledge are individual predisposing characteristics that temporally precede the decision to use a health service such as vaccination.46 However, although we feel it is less likely, the reverse relationship is possible: that parents who have already chosen not to vaccinate their child feel pressured by conventional medicine and thus choose to pursue CAM.

Conclusions

From 2001 to 2010, significant progress was made in reducing disparities across many domains in many vaccinations among US children, largely in part due to the Vaccines For Children program.77 Furthermore, in 2010, the Patient Protection and Affordable Care Act began requiring all new health plans to cover routinely recommended vaccinations (including influenza vaccination) without cost-sharing.33 Significant disparities remain, however.77 The findings from this study suggest that children who have ever used any type of AMS or MBBT (ie, CAM types more likely to result in contact with CAM practitioners documented as advising alternative vaccine schedules or against vaccination) should be considered as a group vulnerable to low annual uptake of influenza vaccination. Although more and more patients are using CAM and may be expecting health professionals to guide them in making decisions about whether CAM and/or conventional approaches work better for disease treatment or prevention, most CAM users do not disclose to their physicians that they use CAM.74 At the same time, there is increasing vaccine hesitancy in the United States. However, there is very limited research on how vaccination perspectives develop among CAM practitioners- and medical practitioners-in-training.78 There is opportunity for US public health, policy, and conventional medical professionals and educators to improve vaccine uptake and child health by better engaging both CAM and conventional medicine practitioners-in-training, parents of children using particular domains of CAM, and the CAM practitioners advising them.

Glossary

AMS

alternative medical systems

BBT

biologically based therapy

CAL

Child Complementary and Alternative Medicine File of the National Health Interview Survey

CAM

complementary and alternative medicine

MBBT

manipulative and body-based therapy

MBT

mind–body therapy

NHIS

National Health Interview Survey

Footnotes

Dr Bleser conceptualized the study, conducted data analyses, and led the writing and revision of the manuscript; Ms Elewonibi helped to conceptualize the analysis, helped to write the manuscript, and critically reviewed and revised the manuscript; Drs BeLue and Miranda supervised the research project, helped to conceptualize the analysis, and critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

FINANCIAL DISCLOSURE: Dr Bleser is providing consultation on mumps vaccine litigation unrelated to this study. The other authors have indicated they have no financial relationships relevant to this article to disclose.

FUNDING: Supported by the Department of Health Policy and Administration at Pennsylvania State University. The authors acknowledge assistance provided by the Population Research Institute at Pennsylvania State University, which is supported by an infrastructure grant from the National Institutes of Health (2R24HD041025-11). This publication was also supported, in part, by grants UL1 TR000127 and KL2 TR000126 from the National Center for Advancing Translational Sciences. Funded by the National Institutes of Health (NIH).

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

References

  • 1.Jacobson RM, Zabel KS, Poland GA. The challenge of vaccine safety. Semin Pediatr Infect Dis. 2002;13(3):215–220 [DOI] [PubMed] [Google Scholar]
  • 2.van Panhuis WG, Grefenstette J, Jung SY, et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med. 2013;369(22):2152–2158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: causes, consequences, and a call to action. Am J Prev Med. 2015;49(6 suppl 4):S391–S398 [DOI] [PubMed] [Google Scholar]
  • 4.Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014;32(19):2150–2159 [DOI] [PubMed] [Google Scholar]
  • 5.Poland GA, Jacobson RM. Understanding those who do not understand: a brief review of the anti-vaccine movement. Vaccine. 2001;19(17-19):2440–2445 [DOI] [PubMed] [Google Scholar]
  • 6.Schwartz JL, Caplan AL. Vaccination refusal: ethics, individual rights, and the common good. Prim Care. 2011;38(4):717–728, ix [DOI] [PubMed] [Google Scholar]
  • 7.Chatterjee A, O’Keefe C. Current controversies in the USA regarding vaccine safety. Expert Rev Vaccines. 2010;9(5):497–502 [DOI] [PubMed] [Google Scholar]
  • 8.Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008;(12):1–23 [PubMed] [Google Scholar]
  • 9.Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Rep. 2015; (79):1–16 [PMC free article] [PubMed] [Google Scholar]
  • 10.Nahin RL, Dahlhamer JM, Stussman BJ. Health need and the use of alternative medicine among adults who do not use conventional medicine. BMC Health Serv Res. 2010;10(1):220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Elewonibi BR, BeLue R. Prevalence of complementary and alternative medicine in immigrants. J Immigr Minor Health. 2016;18(3):600–607 [DOI] [PubMed] [Google Scholar]
  • 12.Ernst E. Rise in popularity of complementary and alternative medicine: reasons and consequences for vaccination. Vaccine. 2001;20(suppl 1):S90–S93; discussion S89 [DOI] [PubMed] [Google Scholar]
  • 13.Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics. 2000;106(5):1097–1102 [DOI] [PubMed] [Google Scholar]
  • 14.Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med. 2005;159(5):470–476 [DOI] [PubMed] [Google Scholar]
  • 15.Wilson K, Mills E, Boon H, Tomlinson G, Ritvo P. A survey of attitudes towards paediatric vaccinations amongst Canadian naturopathic students. Vaccine. 2004;22(3–4):329–334 [DOI] [PubMed] [Google Scholar]
  • 16.Busse JW, Wilson K, Campbell JB. Attitudes towards vaccination among chiropractic and naturopathic students. Vaccine. 2008;26(49):6237–6243 [DOI] [PubMed] [Google Scholar]
  • 17.Ali A, Calabrese C, Lee R, Salmon D, Zwickey H. Vaccination attitudes and education in naturopathic medicine students [abstract]. J Altern Complement Med. 2014;20(5):A115–A116 [Google Scholar]
  • 18.Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333–1340 [DOI] [PubMed] [Google Scholar]
  • 19.Centers for Disease Control and Prevention (CDC) . Estimates of deaths associated with seasonal influenza—United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59(33):1057–1062 [PubMed] [Google Scholar]
  • 20.Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–5096 [DOI] [PubMed] [Google Scholar]
  • 21.Jones L, Sciamanna C, Lehman E. Are those who use specific complementary and alternative medicine therapies less likely to be immunized? Prev Med. 2010;50(3):148–154 [DOI] [PubMed] [Google Scholar]
  • 22.Davis MA, Smith M, Weeks WB. Influenza vaccination among chiropractic patients and other users of complementary and alternative medicine: are chiropractic patients really different? Prev Med. 2012;54(1):5–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Stokley S, Cullen KA, Kennedy A, Bardenheier BH. Adult vaccination coverage levels among users of complementary/alternative medicine—results from the 2002 National Health Interview Survey (NHIS). BMC Complement Altern Med. 2008;8:6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Centers for Disease Control and Prevention Influenza. In: Atkinson W, Wolfe C, Hamborsky J, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed, second printing. Washington, DC: Public Health Foundation; 2012:151–172. Available at: www.cdc.gov/vaccines/pubs/pinkbook/downloads/flu.pdf. Accessed March 9, 2015
  • 25.Fiore AE, Uyeki TM, Broder K, et al. ; Centers for Disease Control and Prevention (CDC) . Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1–62 [PubMed] [Google Scholar]
  • 26.Principi N, Esposito S. Are we ready for universal influenza vaccination in paediatrics? Lancet Infect Dis. 2004;4(2):75–83 [DOI] [PubMed] [Google Scholar]
  • 27.Teo SS, Nguyen-Van-Tam JS, Booy R. Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps? Arch Dis Child. 2005;90(5):532–536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Jordan R, Connock M, Albon E, et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine. 2006;24(8):1047–1062 [DOI] [PubMed] [Google Scholar]
  • 29.Poehling KA, Edwards KM, Weinberg GA, et al. ; New Vaccine Surveillance Network . The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40 [DOI] [PubMed] [Google Scholar]
  • 30.Centers for Disease Control and Prevention Children, the flu, and the flu vaccine. Available at: www.cdc.gov/flu/protect/children.htm. Accessed May 5, 2014
  • 31.Centers for Disease Control and Prevention Influenza vaccine safety. Available at: www.cdc.gov/flu/protect/vaccine/vaccinesafety.htm. Accessed March 27, 2014
  • 32.Centers for Disease Control and Prevention Vaccines for Children Program (VFC). Available at: www.cdc.gov/vaccines/programs/vfc/about/index.html. Accessed April 3, 2015
  • 33.US Department of Health and Human Services (DHHS) The Affordable Care Act and immunizations. Available at: www.hhs.gov/healthcare/facts-and-features/fact-sheets/aca-and-immunization/index.html. Accessed April 18, 2016
  • 34.Centers for Disease Control and Prevention Vaccine effectiveness—how well does the flu vaccine work? Available at: www.cdc.gov/flu/about/qa/vaccineeffect.htm. Accessed March 31, 2015
  • 35.Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36–44 [DOI] [PubMed] [Google Scholar]
  • 36.Lu P, Santibanez TA, Williams WW, et al. Surveillance of influenza vaccination coverage—United States, 2007-08 through 2011-12 influenza seasons. Morb Mortal Wkly Rep Surveill Summ. 2013;62(4):1–28 [PubMed] [Google Scholar]
  • 37.Elam-Evans LD, Yankey D, Singleton JA, Kolasa M; Centers for Disease Control and Prevention (CDC) . National, state, and selected local area vaccination coverage among children aged 19-35 months—United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(34):741–748 [PMC free article] [PubMed] [Google Scholar]
  • 38.Black LI, Clarke TC, Barnes PM, Stussman BJ, Nahin RL. Use of complementary health approaches among children aged 4-17 years in the United States: National Health Interview Survey, 2007-2012. Natl Health Stat Rep. 2015;(78):1–19 [PMC free article] [PubMed] [Google Scholar]
  • 39.Downey L, Tyree PT, Huebner CE, Lafferty WE. Pediatric vaccination and vaccine-preventable disease acquisition: associations with care by complementary and alternative medicine providers. Matern Child Health J. 2010;14(6):922–930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.National Center for Health Statistics, Centers for Disease Control and Prevention National Health Interview Survey fact sheet. Available at: www.cdc.gov/nchs/data/factsheets/NHIS_2014.pdf. Accessed September 3, 2015
  • 41.Division of Health Interview Statistics, National Center for Health Statistics, National Center for Health Statistics 2012 National Health Interview Survey (NHIS) public use data release: NHIS survey description. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2012/srvydesc.pdf. Accessed September 3, 2015
  • 42.Brown CM, Barner JC, Richards KM, Bohman TM. Patterns of complementary and alternative medicine use in African Americans. J Altern Complement Med. 2007;13(7):751–758 [DOI] [PubMed] [Google Scholar]
  • 43.Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;2(343):1–19 [PubMed] [Google Scholar]
  • 44.Saydah SH, Eberhardt MS. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med. 2006;12(8):805–812 [DOI] [PubMed] [Google Scholar]
  • 45.National Center for Complementary and Integrative Health What is complementary and alternative medicine? Available at: https://nccih.nih.gov/health/integrative-health
  • 46.Andersen R, Rice TH, Kominski GF, eds. Changing the U.S. Health Care System: Key Issues in Health Services Policy and Management. 3rd ed. San Francisco, CA: Jossey-Bass; 2007 [Google Scholar]
  • 47.Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s Behavioral Model of Health Services Use: a systematic review of studies from 1998-2011. Psychosoc Med. 2012;9:Doc11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.StataCorp Stata Statistical Software: Release 14 [computer program]. College Station, TX: StataCorp LP; 2015 [Google Scholar]
  • 49.Gaglani M, Riggs M, Kamenicky C, Glezen WP. A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease. Pediatr Infect Dis J. 2001;20(12):1155–1160 [DOI] [PubMed] [Google Scholar]
  • 50.Marshall BC, Henshaw C, Evans DA, Bleyl K, Alder S, Liou TG. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics. 2002;109(5). Available at: www.pediatrics.org/cgi/content/full/109/5/E80 [DOI] [PubMed] [Google Scholar]
  • 51.Poehling KA, Speroff T, Dittus RS, Griffin MR, Hickson GB, Edwards KM. Predictors of influenza virus vaccination status in hospitalized children. Pediatrics. 2001;108(6). Available at: www.pediatrics.org/cgi/content/full/108/6/E99 [DOI] [PubMed] [Google Scholar]
  • 52.Poehling KA, Fairbrother G, Zhu Y, et al. ; New Vaccine Surveillance Network . Practice and child characteristics associated with influenza vaccine uptake in young children. Pediatrics. 2010;126(4):665–673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Uwemedimo OT, Findley SE, Andres R, Irigoyen M, Stockwell MS. Determinants of influenza vaccination among young children in an inner-city community. J Community Health. 2012;37(3):663–672 [DOI] [PubMed] [Google Scholar]
  • 54.Allison MA, Reyes M, Young P, et al. Parental attitudes about influenza immunization and school-based immunization for school-aged children. Pediatr Infect Dis J. 2010;29(8):751–755 [DOI] [PubMed] [Google Scholar]
  • 55.Daley MF, Beaty BL, Barrow J, et al. Missed opportunities for influenza vaccination in children with chronic medical conditions. Arch Pediatr Adolesc Med. 2005;159(10):986–991 [DOI] [PubMed] [Google Scholar]
  • 56.Daley MF, Crane LA, Chandramouli V, et al. Influenza among healthy young children: changes in parental attitudes and predictors of immunization during the 2003 to 2004 influenza season. Pediatrics. 2006;117(2). Available at: www.pediatrics.org/cgi/content/full/117/2/e268 [DOI] [PubMed] [Google Scholar]
  • 57.Flood EM, Rousculp MD, Ryan KJ, et al. Parents’ decision-making regarding vaccinating their children against influenza: a web-based survey. Clin Ther. 2010;32(8):1448–1467 [DOI] [PubMed] [Google Scholar]
  • 58.Gnanasekaran SK, Finkelstein JA, Hohman K, O’Brien M, Kruskal B, Lieu T Parental perspectives on influenza vaccination among children with asthma. Public Health Rep 2006;121(2):181–188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Hemingway CO, Poehling KA. Change in recommendation affects influenza vaccinations among children 6 to 59 months of age. Pediatrics. 2004;114(4):948–952 [DOI] [PubMed] [Google Scholar]
  • 60.Lin CJ, Nowalk MP, Zimmerman RK, et al. Beliefs and attitudes about influenza immunization among parents of children with chronic medical conditions over a two-year period. J Urban Health. 2006;83(5):874–883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Lin CJ, Zimmerman RK, Nowalk MP, et al. Parental perspectives on influenza vaccination of children with chronic medical conditions. J Natl Med Assoc. 2006;98(2):148–153 [PMC free article] [PubMed] [Google Scholar]
  • 62.Ma KK, Schaffner W, Colmenares C, Howser J, Jones J, Poehling KA. Influenza vaccinations of young children increased with media coverage in 2003. Pediatrics. 2006;117(2). Available at: www.pediatrics.org/cgi/content/full/117/2/e157 [DOI] [PubMed] [Google Scholar]
  • 63.Mirza A, Subedar A, Fowler SL, et al. Influenza vaccine: awareness and barriers to immunization in families of children with chronic medical conditions other than asthma. South Med J. 2008;101(11):1101–1105 [DOI] [PubMed] [Google Scholar]
  • 64.Nowalk MP, Zimmerman RK, Lin CJ, et al. Parental perspectives on influenza immunization of children aged 6 to 23 months. Am J Prev Med. 2005;29(3):210–214 [DOI] [PubMed] [Google Scholar]
  • 65.Nowalk MP, Lin CJ, Zimmerman RK, et al. Changes in parents’ perceptions of infant influenza vaccination over two years. J Natl Med Assoc. 2007;99(6):636–641 [PMC free article] [PubMed] [Google Scholar]
  • 66.Simon AE, Ahrens KA, Akinbami LJ. Influenza vaccination among US children with asthma, 2005-2013. Acad Pediatr. 2016;16(1):68–74 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Szilagyi PG, Rodewald LE, Savageau J, Yoos L, Doane C. Improving influenza vaccination rates in children with asthma: a test of a computerized reminder system and an analysis of factors predicting vaccination compliance. Pediatrics. 1992;90(6):871–875 [PubMed] [Google Scholar]
  • 68.Gnanasekaran SK, Finkelstein JA, Lozano P, Farber HJ, Chi FW, Lieu TA. Influenza vaccination among children with asthma in Medicaid managed care. Ambul Pediatr. 2006;6(1):1–7 [DOI] [PubMed] [Google Scholar]
  • 69.Santibanez TA, Lu PJ, O’Halloran A, Meghani A, Grabowsky M, Singleton JA Trends in childhood influenza vaccination coverage—US, 2004-2012. Public Health Rep 2014;129(5):417–427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Santibanez TA, Santoli JM, Bridges CB, Euler GL. Influenza vaccination coverage of children aged 6 to 23 months: the 2002-2003 and 2003-2004 influenza seasons. Pediatrics. 2006;118(3):1167–1175 [DOI] [PubMed] [Google Scholar]
  • 71.Wang E, Clymer J, Davis-Hayes C, Buttenheim A. Nonmedical exemptions from school immunization requirements: a systematic review. Am J Public Health. 2014;104(11):e62–e84 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Gullion JS, Henry L, Gullion G. Deciding to opt out of childhood vaccination mandates. Public Health Nurs. 2008;25(5):401–408 [DOI] [PubMed] [Google Scholar]
  • 73.Buttenheim A, Jones M, Baras Y. Exposure of California kindergartners to students with personal belief exemptions from mandated school entry vaccinations. Am J Public Health. 2012;102(8):e59–e67 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Committee on the Use of Complementary and Alternative Medicine by the American Public, Board on Health Promotion and Disease Prevention, Institute of Medicine Complementary and Alternative Medicine in the United States. Washington, DC: National Academies Press; 2005. Available at: www.nap.edu/catalog/11182. Accessed December 10, 2015
  • 75.Mendiola J, Do-Reynoso V, Gonzalez M. Generation status as a determinant of influenza vaccination among Mexican-identified adults in California, 2011-12. Prev Med Rep. 2015;3:25–29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Buelow VH, Van Hook J. Timely immunization series completion among children of immigrants. J Immigr Minor Health. 2008;10(1):37–44 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Zhao Z, Smith PJ. Trends in vaccination coverage disparities among children, United States, 2001-2010. Vaccine. 2013;31(19):2324–2327 [DOI] [PubMed] [Google Scholar]
  • 78.McMurtry A, Wilson K, Clarkin C, et al. The development of vaccination perspectives among chiropractic, naturopathic and medical students: a case study of professional enculturation. Adv Health Sci Educ Theory Pract. 2015;20(5):1291–1302 [DOI] [PubMed] [Google Scholar]

Articles from Pediatrics are provided here courtesy of American Academy of Pediatrics

RESOURCES